DAE HWA Pharmaceutical Co., Ltd. (KOSDAQ:067080)

DAE HWA Pharmaceutical Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 15, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	259,246	191,632	164,306	164,657	163,255	269,902
Market Cap Growth	47.68%	16.63%	-0.21%	0.86%	-39.51%	21.16%
Enterprise Value	355,335	288,813	265,142	243,200	219,445	325,800
Last Close Price	14800.00	10902.01	9214.79	9080.87	8847.03	14454.43
PE Ratio	397.46	360.61	-	147.59	73.63	-
PS Ratio	1.75	1.28	1.16	1.25	1.39	2.47
PB Ratio	3.54	2.51	2.12	2.02	1.96	3.13
P/TBV Ratio	6.66	4.49	3.67	3.27	2.96	4.49
P/FCF Ratio	44.95	218.93	-	-	232.62	-
P/OCF Ratio	31.01	36.50	-	20.10	15.72	101.72
EV/Sales Ratio	2.39	1.93	1.88	1.84	1.87	2.98
EV/EBITDA Ratio	27.74	22.02	33.85	23.41	27.08	33.90
EV/EBIT Ratio	54.48	43.03	135.12	41.60	66.82	82.64
EV/FCF Ratio	61.61	329.96	-	-	312.68	-
Debt / Equity Ratio	1.34	1.30	1.43	1.10	0.84	0.74
Debt / EBITDA Ratio	7.67	7.57	14.11	8.67	8.66	6.61
Debt / FCF Ratio	17.03	113.42	-	-	99.96	-
Asset Turnover	0.71	0.70	0.68	0.70	0.67	0.64
Inventory Turnover	3.19	3.35	3.86	4.10	3.85	3.63
Quick Ratio	0.23	0.25	0.29	0.33	0.49	0.39
Current Ratio	0.49	0.52	0.51	0.62	0.75	0.66
Return on Equity (ROE)	1.05%	1.08%	-0.65%	1.48%	2.31%	-2.92%
Return on Assets (ROA)	1.96%	1.97%	0.59%	1.94%	1.17%	1.44%
Return on Capital (ROIC)	2.30%	2.31%	0.68%	2.25%	1.35%	1.73%
Return on Capital Employed (ROCE)	8.10%	7.60%	2.20%	5.00%	3.20%	4.00%
Earnings Yield	0.25%	0.28%	-0.70%	0.68%	1.36%	-0.74%
FCF Yield	2.22%	0.46%	-5.55%	-11.84%	0.43%	-0.41%
Dividend Yield	1.01%	-	-	-	-	-
Payout Ratio	402.83%	494.43%	-	235.51%	118.28%	-
Buyback Yield / Dilution	1.85%	0.72%	-1.21%	0.16%	-0.87%	1.48%
Total Shareholder Return	2.87%	0.72%	-1.21%	0.16%	-0.87%	1.48%

Updated May 14, 2020. Source: S&P Global Market Intelligence. Standard template. Financial Sources.